Featuring the new read-and-publish deal between Elsevier and Carnegie Mellon University, a beta repository for research from UK cultural and heritage organizations and the range of APC across publishers
Featuring highlights from the ISMPP U webinar on plain-language summaries, lessons learned from the YODA Project and the benefits of Wiley’s ‘Under Review’ service.
Featuring the proposed concept of geowalling, highlights from World Science Day 2019, the Health Research Authority’s trip to the House of Commons and ISMPP’s support of the Open Pharma position statement.
Featuring the return of ‘Unreported clinical trial of the week’, exciting opportunities in the age of digital publishing and a new pilot to make comments on preprints publicly available
Featuring a sneak preview of responses to the Health Research Authority ‘Make it Public’ consultation, an investigation into researchers’ communication with study participants and the worldwide spread of endorsements for the Open Pharma position statement on open access
Featuring the launch of the Open Pharma position statement on open access, an introduction to the Open Science in Action Inaugural Symposium and a call to action for the UK government to do more to ensure transparent clinical trial reporting.
ORCID is part of the wider digital infrastructure needed for researchers to share information on a global scale. ORCID enables transparent and trustworthy connections between researchers, their contributions, and affiliations by providing an identifier for individuals to use with their name as they engage in research, scholarship and innovation activities. The Open Pharma community is … Continue reading Guest post: ORCID adoption in the pharma community
Featuring researchers’ fears surrounding clinical trial registries, a roundup of the events planned for Open Access Week 2019 and the release of the Open Pharma Charter
Featuring the upcoming MedComms Brunch Meeting on open access, an investigation into the future of open access publishing, news from the third Asia Pacific Meeting of ISMPP and the scientific community’s toxic definition of success
Featuring the Open Pharma and Pint of Science crossover event, a new pilot project to facilitate the transparent review of preprints and the results from a Nature poll on coercive citations